Karl Swedberg

Summary

Country: Germany

Publications

  1. pmc Phosphodiesterase 4 inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock
    Andreas Link
    Klinik fur Innere Medizin III, Universitat des Saarlandes, 66421 Homburg Saar, Germany
    Crit Care 12:R159. 2008
  2. pmc Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study
    Andreas Link
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Kirrberger Strasse, 66421 Homburg Saar, Germany
    Crit Care 12:R111. 2008
  3. doi [Erectile dysfunction as cardiovascular risk marker. Role of the renin-angiotensin system]
    M Bohm
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar
    Dtsch Med Wochenschr 133:1313-6. 2008
  4. doi Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients
    Michael Bohm
    Klinik für Innere Medizin III Kardiologie, Angiologie, Internistische Intensivmedizin, Universitat des Saarlandes, Kirrberger Strasse, 66424 Homburg Saar, Germany
    Eur Heart J 30:1364-71. 2009
  5. doi Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtoler
    Michael Bohm
    Department of Cardiology, University of the Saarland, Saarbrucken, Germany
    Circulation 121:1439-46. 2010
  6. doi Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
    Michael Bohm
    Universitatsklinikum des Saarlandes, Klinik fur Innere Medizin III, Homburg Saar, Germany
    Lancet 376:886-94. 2010
  7. doi Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart failure
    Jan Christian Reil
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Kardiologie, Angiologie und Internistische Intensivmedizin, Homburg Saar, Germany
    Eur J Heart Fail 15:1044-52. 2013
  8. doi Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study
    Michael Bohm
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Kirrberger Str 1, 66424, Homburg Saar, Germany
    Clin Res Cardiol 102:11-22. 2013
  9. doi Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients
    Jan Christian Reil
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany Electronic address
    J Am Coll Cardiol 62:1977-85. 2013
  10. doi Heart rate reduction in cardiovascular disease and therapy
    Jan Christian Reil
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und, Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Kirrberger Strasse, 66421, Homburg Saar, Germany
    Clin Res Cardiol 100:11-9. 2011

Detail Information

Publications13

  1. pmc Phosphodiesterase 4 inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock
    Andreas Link
    Klinik fur Innere Medizin III, Universitat des Saarlandes, 66421 Homburg Saar, Germany
    Crit Care 12:R159. 2008
    ....
  2. pmc Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study
    Andreas Link
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Kirrberger Strasse, 66421 Homburg Saar, Germany
    Crit Care 12:R111. 2008
    ..The reversible platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban was investigated to preserve platelet number and activation in a prospective open-blinded endpoint evaluation study...
  3. doi [Erectile dysfunction as cardiovascular risk marker. Role of the renin-angiotensin system]
    M Bohm
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar
    Dtsch Med Wochenschr 133:1313-6. 2008
  4. doi Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients
    Michael Bohm
    Klinik für Innere Medizin III Kardiologie, Angiologie, Internistische Intensivmedizin, Universitat des Saarlandes, Kirrberger Strasse, 66424 Homburg Saar, Germany
    Eur Heart J 30:1364-71. 2009
    ..To investigate the relationship between microalbuminuria (MAU) and atrial fibrillation (AF) and to further evaluate whether the heart rate dependency of MAU in patients without AF is maintained in patients with a history of AF...
  5. doi Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtoler
    Michael Bohm
    Department of Cardiology, University of the Saarland, Saarbrucken, Germany
    Circulation 121:1439-46. 2010
    ....
  6. doi Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
    Michael Bohm
    Universitatsklinikum des Saarlandes, Klinik fur Innere Medizin III, Homburg Saar, Germany
    Lancet 376:886-94. 2010
    ..We aimed to test our hypothesis by investigating the association between heart rate and events in this patient population...
  7. doi Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart failure
    Jan Christian Reil
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Kardiologie, Angiologie und Internistische Intensivmedizin, Homburg Saar, Germany
    Eur J Heart Fail 15:1044-52. 2013
    ..Therefore, we aimed to analyse the impact of LBBB on outcomes in patients with systolic HF as a function of heart rate, and the relationship between LBBB and the effect of treatment with ivabradine...
  8. doi Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study
    Michael Bohm
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Kirrberger Str 1, 66424, Homburg Saar, Germany
    Clin Res Cardiol 102:11-22. 2013
    ..A cut-off value of ≥75 bpm was chosen by the EMEA for approval for the use of ivabradine in chronic heart failure...
  9. doi Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients
    Jan Christian Reil
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany Electronic address
    J Am Coll Cardiol 62:1977-85. 2013
    ..The study aimed to determine whether isolated heart rate (HR) reduction with ivabradine reduces afterload of patients with systolic heart failure...
  10. doi Heart rate reduction in cardiovascular disease and therapy
    Jan Christian Reil
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und, Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Kirrberger Strasse, 66421, Homburg Saar, Germany
    Clin Res Cardiol 100:11-9. 2011
    ..Heart rate can be easily determined during physical examination of the patient and therefore allows a simple hint on prognosis and efficiency of therapy...
  11. doi Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)
    Michael Bohm
    Universitatsklinikum des Saarlandes, Klinik fur Innere Medizin III, Homburg Saar, Germany Electronic address
    Am J Cardiol 116:1890-7. 2015
    ..In conclusion, cardiac and noncardiac co-morbidities significantly affect CV outcomes, particularly if there are >3 co-morbidities. The effect of heart rate reduction with ivabradine is maintained at all co-morbidity loads. ..
  12. doi Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy
    Michael Bohm
    Universitatsklinikum des Saarlandes, Klinik fur Innere Medizin III, Homburg Saar, Germany
    Eur J Heart Fail 17:518-26. 2015
    ....
  13. doi The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials
    Stefan D Anker
    Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin D 13353, Germany Department of Cardiology, University Medical Center, Gottingen, Germany
    Eur Heart J 35:2001-9. 2014
    ..This process of integrating PRO data into comprehensive efficacy evaluations will ultimately improve the quality of care for patients across the spectrum of cardiovascular disease. ..